Minerva Neurosciences NERV
NASDAQ NERV
$4.43 -0.26 (-5.54%)
At close: Sep 4, 2026 · 4:00 PM EDT

Minerva Neurosciences (NERV) Other Non-Current Assets (2013 - 2021)

Minerva Neurosciences' (NERV) quarterly Other Non-Current Assets came in at $14808.0 in Q2 2021, little changed YoY from $14808.0 in Q2 2020, and little changed on a QoQ basis from $14808.0 in Q1 2021.

Analysis

Minerva Neurosciences (NERV) Other Non-Current Assets (2013 - 2021) Analysis & Trends

Minerva Neurosciences (NERV) has 7 years of Other Non-Current Assets data on file, last reported at $14808.0 in Q2 2021.

  • Quarterly Other Non-Current Assets changed 0.0% year-over-year to $14808.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $14808.0 (changed 0.0% YoY) and the FY2020 annual result came in at $14808.0, changed 0.0% from the prior year.
  • Other Non-Current Assets steadied at $14808.0 in Q2 2021, from $14808.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $14808.0 in Q4 2017 to a low of $14808.0 in Q4 2017.
  • A 5-year average of $14808.0 and a median of $14808.0 in 2017 frame the typical range for Other Non-Current Assets.
  • The widest YoY moves for Other Non-Current Assets: up 0.0% in 2018, down 0.0% in 2018.
  • Tracing NERV's Other Non-Current Assets over 5 years: stood at $14808.0 in 2017, then changed by 0.0% to $14808.0 in 2018, then changed by 0.0% to $14808.0 in 2019, then changed by 0.0% to $14808.0 in 2020, then changed by 0.0% to $14808.0 in 2021.
  • The last three Other Non-Current Assets figures came in at $14808.0 (Q2 2021), $14808.0 (Q1 2021), and $14808.0 (Q4 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 42.45 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 62.96 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 104.44 Mn
10 Minerva Neurosciences 207.37 Mn 207.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 14,808.00
Mar 31, 2021 14,808.00
Dec 31, 2020 14,808.00
Sep 30, 2020 14,808.00
Jun 30, 2020 14,808.00
Mar 31, 2020 14,808.00
Dec 31, 2019 14,808.00
Sep 30, 2019 14,808.00
Jun 30, 2019 14,808.00
Mar 31, 2019 14,808.00
Dec 31, 2018 14,808.00
Sep 30, 2018 14,808.00
Jun 30, 2018 14,808.00
Mar 31, 2018 14,808.00
Dec 31, 2017 14,808.00
Jun 30, 2014 3.11 Mn
Dec 31, 2013 433,998.00